Cardiac Interventions Today’s Post

🌍 Exciting News! We are teaming up with the International PNH Interest Group (IPIG) to improve care for people with Paroxysmal Nocturnal Hemoglobinuria (PNH) in low-resource countries. PNH is a rare and debilitating blood disease that requires frequent blood transfusions and poses a high risk without treatment. This powerful collaboration will bring cutting-edge treatments and vital medical training to 53 countries, tackling the severe challenges of this rare blood disease. With this initiative, healthcare providers will be better equipped to diagnose and treat them effectively. Together, we're breaking down barriers to health equity for those who need it most🌟 https://buff.ly/3VMLhv4 #CancerInnovation #ClosingTheCareGap #TheMaxFoundation

How does the IOTA Model impact kidney transplant hospitals? From incentives to risk-sharing, the six-year mandatory program is setting new benchmarks in care coordination and efficiency. Dive into the details of the finalized rule and what it means for clinical practice. Download the CMS IOTA Participation List Here in our Blog: https://loom.ly/MSL7fYU #HealthEquity #Quality #KidneyTransplant #CMS #FinalRule

Did you know that two thirds of healthcare resources used at end-of life are used in home- and community-based care? Why do we know so little about end-of-life resources use for causes of death other than cancer? Our study team -Gudrun Waaler Bjørnelv Emily Burger Eline Aas Liv Augestad Lisbeth Thoresen - found that healthcare use and costs vary considerably by cause of death. Our disease-specific findings enable decision-makers to make more informed resource-allocation decisions for all causes of death and differentiated for all levels of formal care (primary, secondary, and home- and community-based care). Use our findings in modelling to improve healthcare planing and resource allocation! #regforsk #ism #heled #hszg #HarvardChan Find our open access article here: https://lnkd.in/eG6WQEe7.

In the latest edition of Decoding Health Care, Dr. Michael Kolodziej, Medical Advisor at Canopy, explores the critical role of electronic patient-reported outcomes (ePROs) in chronic illness management, with a special focus on cancer care. Dr. Kolodziej highlights the importance of real-time patient engagement and the significant impact of ePROs in reducing ER visits and improving patient outcomes. At Canopy, we're proud to be at the forefront of this transformation, leveraging our advanced ePRO tools to ensure continuous care and better quality of life for patients. Discover how ePROs are revolutionizing "personalized" patient care. 📖 Read the full article here

VEN Centers and Arizona Liver Health are leading the way in HCV elimination through rapid community collaboration! From January to August 2024, 1631 patients were screened for HCV, and many began life-saving treatment on the same day in a streamlined process. Key Findings: ✅ 328 Individuals with HCV were prescribed DAA treatment through the VEN Centers' program. ✅ The majority of patients from these at-risk populations linked to care were already aware of their HCV diagnosis, particularly in substance use disorder programs. ✅Partnerships between HCV treaters and community organizations is essential to large volume diagnosis and treatment of HCV. Continued innovation and collaboration are vital to ending HCV for good!. Check out the full abstract for more insights on this game-changing approach! #HCVElimination #LiverHealth #PublicHealth #HealthcareInnovation #VENCenters #ArizonaLiverHealth #CommunityCollaboration Dylan Moore Ann Moore Brennin Palfrey Anita Kohli Richard Manch Colleen Hopkins Kylee Newgass Tessa Janovsky Gavin Ferguson Marianne Rosati Rida Nadeem, MD, MSPH Chelsea Ann Mihaylo Hum, PMP AbbVie Gilead Sciences Jake Winans, MSN, RN, FNP-C Amy Rust Michelle Jones Kelly Black Nick Engelke

Urgent Call for a More Integrated Approach in NHS Services!! After dedicating a combined 75 years to working in the NHS, my husband and I have experienced firsthand the challenges faced by patients within the system. Recently, my husband was diagnosed with prostate cancer. Shockingly, despite our deep familiarity with the NHS, we had to turn to private healthcare to receive a timely diagnosis. Now, facing another health concern! —we find ourselves navigating a fragmented system. Instead of seeing his consultant, he has been offered an appointment at a different hospital, different consultant scheduled for the beginning of August. This delay and lack of continuity in care highlight a critical gap in our healthcare system. We have spent the last 2 hours working our way around the system! With today’s technological advancements, it is disheartening to see a lack of integration in patient care within the NHS. We are fortunate to understand how to navigate these complexities, but what about those who do not have our background? It is a tough admission to say that the system is broken, but recognising this is the first step toward meaningful reform. We need an NHS that champions not only advanced technologies but also a truly integrated approach to patient care, ensuring that every patient receives timely and consistent treatment. #NHSReform #Healthcare #PatientCare

Hospital costs for those with #HFrEF tend to be high – yet the factors that contribute to these costs vary significantly. DCRI Fellow Veraprapat Kittipibul sat down with HCPLive at #ACC24 to discuss what key data from the GWTG-HF registry, and how implementation science can reduce HF-related hospitalizations and costs: https://lnkd.in/esYZCPdv #clinicaltrials #clinicalresearch #heartfailure #patientcosts

ASN president opens ASN Kidney Week with call to redefine the standard of care! One of the highlights from the recent ASN Kidney Week was the organization’s strengthened partnerships across the healthcare landscape. Key updates included ASN’s collaboration with federal agencies to boost funding and shape policies that drive impactful change in kidney care. These initiatives are a significant step toward closing gaps in resources and accessibility for patients. ARC Dialysis supports these initiatives, we have lost to many patients with declining renal function and the mortality rates for dialysis cry for  improvement.  Instead of fistula first, let’s think transplant 1st.  Quality of life matters. https://lnkd.in/g_2_hrNS #ASN #kidneyweek #dialysis

Review of of nurse-led care (NLC) vs Rheum-led (RLC) vs Usual care in RA pts - 14 studies, 3369 pts. shows NLC proves highly effective in managing RA patients, surpassing usual care and equating to rheumatologist-led care in primary and secondary outcomes.

We're thrilled to announce a new partnership between mejo and the IgG4ward! Foundation to create IgG4ME!—a care coordination app tailored for individuals living in the US with IgG4-Related Disease (IgG4-RD). Launching in early 2025, this free app will empower IgG4-RD patients and caregivers to: ·      Log symptoms and track flares ·      Manage medications ·      Store and share medical documents ·      Communicate updates with healthcare providers John Stone MD, MPH of the IgG4ward! Foundation shared why this collaboration is vital: "Managing IgG4-RD often feels overwhelming, with multiple organ systems, specialists, and diagnostic procedures to track. We're excited to partner with mejo to deliver IgG4ME!, a customized companion to help patients rise to the challenge." At mejo, we’re honored to expand our work in rare diseases to include adult patients and simplify care coordination for the IgG4-RD community. As our Co-Founder Bret Koncak said: "This partnership reflects our mission to empower rare disease patients and caregivers with tools that truly make a difference." Read the full press release here  #IgG4RD #RareDisease #CareCoordination #HealthTech #mejo